$2.3m annual revenue and what’s our market cap? $5.1m. Irrational multiple, only in the OTC. CBD mushrooms and seeking out recreational marijuana license life sciences company.
Analyst reports say this should be trading at 13 cents.
But no PR right now. This is an amazing entry point. We’re rapidly growing revenues over last 2 years.
This is a huge winner but we’re building a company, not a stock. Buy 50k or 100k shares and let it marinate.
That’s for anyone coming to the board for the first time.